LifeMap Sciences develops and commercializes next-generation sequencing (NGS) analysis solutions. The company's core technology, the GeneCards Suite Knowledgebase, provides a tool to improve biomedical research and healthcare.

IDEA Bio-Medical is a commercial-stage company specializing in solutions for biological cell-imaging research, drug-discovery automation, and diagnostics.

Immunity Pharma (IPL) develops therapies for neurodegenerative diseases with an initial focus on amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease.

miCure Therapeutics is a biotechnology company leveraging microRNA-based therapeutics and diagnostics for neurodegenerative and psychiatric disorders.

Neurogenic is a clinical-stage diagnostics company advancing the development of a novel ELISA-based immunoassay to detect pathological Platelet-Associated Antibodies (PAA) in the sera of adolescent and pediatric patients to facilitate the diagnosis of early-onset schizophrenia.

SynVaccine has developed a CAD/CAM platform for designing and fabricating designer viruses for biotechnology.

BiomX is a microbiome company developing customized phage therapies designed to target and destroy harmful bacteria in chronic diseases such as inflammatory bowel disease (IBD) and colorectalcancer (CRC), as well as bacteria that affect the appearance of the skin.

NanoCell Ltd. is dedicated to advancing women’s reproductive health through biopharmaceutical technologies that significantly improve embryo implantation, consequently increasing the chances of conceiving.

ImmunoBrain Checkpoint (IBC) is a biopharmaceutical company focused on developing a pipeline of disease-modifying immunotherapies for neurological disorders by targeting immune checkpoint pathways.

FreezeM offers a technology designed to improve the use of insects as a protein source for animal feed. Its products are designed to overcome a number of the limitations of using insects as a protein source, including cost, availability, and regulatory concerns.